No abstract available
MeSH terms
-
Ambulatory Care Facilities / ethics
-
Cardiac Surgical Procedures / instrumentation
-
Cardiovascular System / drug effects
-
Conflict of Interest / economics*
-
Cyclooxygenase 2 Inhibitors / economics
-
Drug Industry* / economics
-
Drug Industry* / ethics
-
Equipment and Supplies* / economics
-
Equipment and Supplies* / ethics
-
Hospital-Physician Relations
-
Humans
-
Investments / ethics
-
Lactones / adverse effects
-
Lactones / economics*
-
Physician-Patient Relations / ethics
-
Physicians / economics*
-
Physicians / ethics
-
Research Personnel / economics
-
Research Personnel / ethics
-
Risk Factors
-
Scientific Misconduct
-
Sulfones / adverse effects
-
Sulfones / economics*
-
United States
-
United States Food and Drug Administration
Substances
-
Cyclooxygenase 2 Inhibitors
-
Lactones
-
Sulfones
-
rofecoxib